WNK2 and breast carcinoma: Since upregulation of mitogenic signals such as Mitogen Activated Protein Kinase (MAPK or ERK1/2) is a common feature of aggressive breast cancers [39] we tested if Rab25 levels alter the activity of ERK kinase.